In the present study, we characterized the Top1 status in three human colon cancer cell lines with acquired resistance to the irinotecan’s metabolite SN-38, investigating Top1 gene copy number, genetic sequence, mRNA and protein expression, enzyme activity and formation of Top1-DNA cleavage complexes following drug treatment of cells. The gene discussed is TOP1; the disease is colonic neoplasm.